Tag Archives: psychedelic research

Psychedelic Therapy Claims in Canada: How to Separate Research, Marketing, and Risk

Interest in psychedelic therapy is growing across Canada, but marketing claims often move faster than clinical evidence. Here is how to assess promises, legal boundaries, provider quality, and personal risk.

Psilocybin Distribution in Canada: What Buyers Should Know About Legal Boundaries, Quality, and Access

News about psychedelic companies, research programs, and criminal cases is changing how Canadians think about psilocybin access. This guide explains the difference between regulated research, unauthorized sales, and responsible consumer education.

Psilocybin Clinical Trials in Canada 2026: What New Research Means for Magic Mushroom Users

Canada’s psychedelic research landscape is shifting fast in 2026, with new clinical trial milestones, policy signals, and commercial production news. Here’s what that means for everyday magic mushroom users, microdosers, and buyers of psilocybin products.

Psilocybin and Emotional Regulation in Canada: What the 2026 Fish Study and New Research Mean for Magic Mushroom Users

A 2026 fish study on psilocybin and aggression has reignited interest in how magic mushrooms affect emotional regulation. Here’s what the science actually shows, what Canadian clinical signals mean, and how users can apply it responsibly.

Psilocybin and LSD Move Toward FDA Approval: What Canada’s Magic Mushroom Community Needs to Know

Psilocybin and LSD are edging closer to FDA approval in the United States — a milestone that could reshape how Canada treats psychedelics. We break down what the news actually says, what it doesn’t, and how it affects Canadian magic mushroom buyers, dispensaries, and delivery services.